[SRNE] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
12-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -87.83%
YoY- -402.33%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 976 101 84 142 134 122 135 274.34%
PBT -10,093 -11,296 -3,356 -4,737 -2,522 -3,236 -1,241 304.93%
Tax 4 4 2 2 2 -3,090 4 0.00%
NP -10,093 -11,296 -3,356 -4,737 -2,522 -1,755 -1,241 304.93%
Tax Rate - - - - - - - -
Total Cost 11,069 11,397 3,440 4,878 2,656 1,877 1,376 301.98%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -1,034.12 -11,217.68 -4,005.73 -3,345.11 -1,881.46 -1,438.58 -922.81 7.89%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -0.44 -0.49 -0.24 -0.35 -0.20 -0.14 -0.10 168.75%
EPS Diluted -0.44 -0.49 -0.24 -0.35 -0.20 -0.14 -0.10 168.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.